Impact of psychosocial comorbidities on clinical outcomes after liver transplantation: Stratification of a high-risk population

Neil Bhogal, Amaninder Dhaliwal, Elizabeth Lyden, Fedja Rochling, Marco Olivera-Martinez

Research output: Contribution to journalArticle

Abstract

Background Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical noncompliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. Aim To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. Methods A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure. Results For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19% vs 10%, P = 0.013). Treatment of psychiatric disorders resulted in a reduction of the incidence of psychiatric decompensation (21% vs 11%, P = 0.022). Patients with a history of polysubstance abuse in the transplant evaluation had a higher incidence of substance abuse after transplantation (5.8% vs 1.2%, P = 0.05). In this cohort, 15 patients (3.8%) were found to have medical compliance issues in the transplant evaluation. Of these specific patients, 13.3% were found to have substance abuse after transplantation as opposed to 1.3% in patients without documented compliance issues (P = 0.03). Conclusion Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this highrisk population.

Original languageEnglish (US)
Pages (from-to)638-645
Number of pages8
JournalWorld Journal of Hepatology
Volume11
Issue number8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Liver Transplantation
Comorbidity
Psychiatry
Transplants
Population
Caregivers
Transplantation
Compliance
Substance-Related Disorders
Liver
Incidence
End Stage Liver Disease
Waiting Lists
Survival
Acute Liver Failure
Standard of Care
Patient Selection
Fibrosis
Alcohols
Guidelines

Keywords

  • Liver transplantation
  • Noncompliance
  • Psychosocial decompensation
  • Recidivism
  • Transplant psychiatry

ASJC Scopus subject areas

  • Hepatology

Cite this

Impact of psychosocial comorbidities on clinical outcomes after liver transplantation : Stratification of a high-risk population. / Bhogal, Neil; Dhaliwal, Amaninder; Lyden, Elizabeth; Rochling, Fedja; Olivera-Martinez, Marco.

In: World Journal of Hepatology, Vol. 11, No. 8, 01.01.2019, p. 638-645.

Research output: Contribution to journalArticle

@article{1411078ae5bf4c5da930f6934655a308,
title = "Impact of psychosocial comorbidities on clinical outcomes after liver transplantation: Stratification of a high-risk population",
abstract = "Background Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical noncompliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. Aim To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. Methods A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure. Results For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19{\%} vs 10{\%}, P = 0.013). Treatment of psychiatric disorders resulted in a reduction of the incidence of psychiatric decompensation (21{\%} vs 11{\%}, P = 0.022). Patients with a history of polysubstance abuse in the transplant evaluation had a higher incidence of substance abuse after transplantation (5.8{\%} vs 1.2{\%}, P = 0.05). In this cohort, 15 patients (3.8{\%}) were found to have medical compliance issues in the transplant evaluation. Of these specific patients, 13.3{\%} were found to have substance abuse after transplantation as opposed to 1.3{\%} in patients without documented compliance issues (P = 0.03). Conclusion Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this highrisk population.",
keywords = "Liver transplantation, Noncompliance, Psychosocial decompensation, Recidivism, Transplant psychiatry",
author = "Neil Bhogal and Amaninder Dhaliwal and Elizabeth Lyden and Fedja Rochling and Marco Olivera-Martinez",
year = "2019",
month = "1",
day = "1",
doi = "10.4254/wjh.v11.i8.638",
language = "English (US)",
volume = "11",
pages = "638--645",
journal = "World Journal of Hepatology",
issn = "1948-5182",
publisher = "Baishideng Publishing Group",
number = "8",

}

TY - JOUR

T1 - Impact of psychosocial comorbidities on clinical outcomes after liver transplantation

T2 - Stratification of a high-risk population

AU - Bhogal, Neil

AU - Dhaliwal, Amaninder

AU - Lyden, Elizabeth

AU - Rochling, Fedja

AU - Olivera-Martinez, Marco

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical noncompliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. Aim To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. Methods A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure. Results For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19% vs 10%, P = 0.013). Treatment of psychiatric disorders resulted in a reduction of the incidence of psychiatric decompensation (21% vs 11%, P = 0.022). Patients with a history of polysubstance abuse in the transplant evaluation had a higher incidence of substance abuse after transplantation (5.8% vs 1.2%, P = 0.05). In this cohort, 15 patients (3.8%) were found to have medical compliance issues in the transplant evaluation. Of these specific patients, 13.3% were found to have substance abuse after transplantation as opposed to 1.3% in patients without documented compliance issues (P = 0.03). Conclusion Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this highrisk population.

AB - Background Liver transplantation is the accepted standard of care for end-stage liver disease due to a variety of etiologies including decompensated cirrhosis, fulminant hepatic failure, and primary hepatic malignancy. There are currently over 13000 candidates on the liver transplant waiting list emphasizing the importance of rigorous patient selection. There are few studies regarding the impact of additional psychosocial barriers to liver transplant including financial hardship, lack of caregiver support, polysubstance abuse, and issues with medical noncompliance. We hypothesized that patients with certain psychosocial comorbidities experienced worse outcomes after liver transplantation. Aim To assess the impact of certain pre-transplant psychosocial comorbidities on outcomes after liver transplantation. Methods A retrospective analysis was performed on all adult patients from 2012-2016. Psychosocial comorbidities including documented medical non-compliance, polysubstance abuse, financial issues, and lack of caregiver support were collected. The primary outcome assessed post-transplantation was survival. Secondary outcomes measured included graft failure, episodes of acute rejection, psychiatric decompensation, number of readmissions, presence of infection, recidivism for alcohol and other substances, and documented caregiver support failure. Results For the primary outcome, there were no differences in survival. Patients with a history of psychiatric disease had a higher incidence of psychiatric decompensation after liver transplantation (19% vs 10%, P = 0.013). Treatment of psychiatric disorders resulted in a reduction of the incidence of psychiatric decompensation (21% vs 11%, P = 0.022). Patients with a history of polysubstance abuse in the transplant evaluation had a higher incidence of substance abuse after transplantation (5.8% vs 1.2%, P = 0.05). In this cohort, 15 patients (3.8%) were found to have medical compliance issues in the transplant evaluation. Of these specific patients, 13.3% were found to have substance abuse after transplantation as opposed to 1.3% in patients without documented compliance issues (P = 0.03). Conclusion Patients with certain psychosocial comorbidities had worse outcomes following liver transplantation. Further prospective and multi-center studies are warranted to properly determine guidelines for liver transplantation regarding this highrisk population.

KW - Liver transplantation

KW - Noncompliance

KW - Psychosocial decompensation

KW - Recidivism

KW - Transplant psychiatry

UR - http://www.scopus.com/inward/record.url?scp=85071740040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071740040&partnerID=8YFLogxK

U2 - 10.4254/wjh.v11.i8.638

DO - 10.4254/wjh.v11.i8.638

M3 - Article

C2 - 31528246

AN - SCOPUS:85071740040

VL - 11

SP - 638

EP - 645

JO - World Journal of Hepatology

JF - World Journal of Hepatology

SN - 1948-5182

IS - 8

ER -